Skip to main content

Table 3 Demographic characteristics of prescriptions

From: Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS)

Characteristic

Prescriptions(N = 5,928,173)

Proportion(%)

Age

0–17

40,784

0.7

18–44

626,509

10.6

45–59

1,361,917

23.0

>60

3,898,963

65.7

Gender

Male

3,380,247

57.0

Female

2,547,926

43.0

Year

2018

1,148,920

19.4

2019

1,195,253

20.2

2020

954,006

16.1

2021

1,064,001

17.9

2022

1,014,192

17.1

First half of 2023

551,801

9.3

Region

Beijing

1,110,187

18.7

Shanghai

958,171

16.2

Guangzhou

1,400,266

23.6

Hangzhou

693,290

11.7

Chengdu

338,935

5.7

Tianjin

364,484

6.2

Zhengzhou

345,553

5.8

Shenyang

Harbin

563,371

153,916

9.5

2.6

Any hospitalization

Inpatient

2,743,931

46.3

Outpatient

3,184,242

53.7

Department visited

Cardiology

2,417,501

40.8

Geriatrics

410,590

6.9

Neurology

274,813

4.6

Endocrinology

235,001

4.0

Others

2,590,268

43.7